Evidence map›Paper›PMID 37779527›Full record

ArticleThe journal of allergy and clinical immunology. Global2023

Overdiagnosis of vaccine allergy: Skin testing and challenge at a public specialized unit (CRIE) in Rio de Janeiro, Brazil.

Luciana Gomes Pedro Brandão, Mari Tuyama, Flávio de Carvalho, Ananza Taina da Silva Santos, Alberto Dos Santos de Lemos, Marcellus Dias da Costa, Emersom Cicilini Mesquita, José Cerbino-Neto, Margareth Catoia Varela, Pedro Emmanuel Alvarenga Americano do Brasil and 1 more

Open access · goldAbstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Luciana Gomes Pedro BrandãoReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Mari TuyamaReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Flávio de CarvalhoReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Ananza Taina da Silva SantosReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Alberto Dos Santos de LemosReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Marcellus Dias da CostaReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Emersom Cicilini MesquitaHealth Surveillance and Immunization Research Unit, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
José Cerbino-NetoHealth Surveillance and Immunization Research Unit, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Margareth Catoia VarelaHealth Surveillance and Immunization Research Unit, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Pedro Emmanuel Alvarenga Americano do BrasilHealth Surveillance and Immunization Research Unit, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Angélica Varela RondonReference Center for Special Immunobiologicals, National Institute of Infectious Disease Evandro Chagas, Rio de Janeiro, Brazil.
Instituto Evandro Chagas · BRD’Or Institute for Research and Education · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vaccination is an extremely safe public health intervention, but rare IgE-mediated adverse events must be identified to avoid the risk of anaphylaxis in the event of reexposure. However, using only clinical history to diagnose previous allergic reactions may lead to overdiagnosis of vaccine allergy and even to the use of medical exemptions as a subterfuge to mandatory vaccination. Methods: We conducted a retrospective study to describe the outcomes of patients with a history of vaccine or vaccine component allergy who were evaluated at our unit from 2011 to 2017. Data on allergy history, skin test results, vaccines prescribed, and adverse events were retrieved from the medical records at the Centro de Referência para Imunobiológicos Especiais (Reference Center of Special Immunobiologicals)-Fiocruz, in Rio de Janeiro, Brazil. Results: Of 34 adults with history of allergy to vaccine or vaccine components, 32 (94.1%) were successfully vaccinated without serious adverse events after our evaluation. In 12 patients (35%), the time elapsed between the allergy symptoms and evaluation in the Centro de Referência para Imunobiológicos Especiais-Fiocruz was more than 10 years. Conclusion: Specialized care and use of skin tests allowed safe vaccination of the majority of patients. An objective, systematic evaluation of a history of vaccine allergy can prevent its improper use to avoid mandatory vaccination and reduce missed opportunities for immunization.

Indexed as

Adultsadverse eventallergyhypersensitivityimmunizationprick testskin allergic testvaccine

Identifiers

PMID37779527
PMCPMC10509850
OpenAlexW4360819953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.